The use of cell secretomes opens a new era of advanced therapies 07/07/2023 Drug discovery Innovative drugs Personalized medicine Advanced therapies The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM) celebrating its 1st... Partners - PEACHES BIOTECH S.L.
European Drug Discovery Innovation & Outsourcing Programme Barcelona España Del 12/09/2023 to 13/09/2023 Healthcare Drug discovery
ZIP Solutions and YIMA Announce Strategic Co-Marketing Agreement for Gene Therapy 05/06/2023 Healthcare Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies International ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech... Partners - Biotechnology Assets
#NewMember | “AseBio connects innovative start-ups with industry and investors” 31/05/2023 Healthcare Drug discovery Meet Telum Therapeutics, our new member. We talked to Roberto Díez-Martínez, CEO y co- founder of the company. AseBio - TELUM THERAPEUTICS
Canadian Intelectual Property Office (CIPO) has conceded ZIP Solutions “Split Inteins and ... 24/03/2023 Healthcare Access to innovation In vitro diagnostics Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies Gene editing International The tool has many biotech applications Partners - Biotechnology Assets
EU Pharmaceutical Law Forum Híbrido - Bruselas (Bélgica) & online Bélgica Del 23/05/2023 to 25/05/2023 Access to innovation Drug discovery
Transforming drug development with digital twins of the heart 21/12/2022 Healthcare Drug discovery Financing Corify Care and GENESIS Biomed will develop a technology platform that uses non-invasive mapping, mathematical models of... AseBio - Corify Care
OLIGOFASTX consortium shares at Farmaforum the progress of the project after 1 year of wor... 06/10/2022 Drug discovery Rare diseases Innovative drugs Industrial biotechnology They have organized the round table "End-to-end technological solution for the development of oligonucleotide-based... Partners
